These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 15025918

  • 1. Oligonucleotide-based strategies to inhibit human hepatitis C virus.
    Martinand-Mari C, Lebleu B, Robbins I.
    Oligonucleotides; 2003; 13(6):539-48. PubMed ID: 15025918
    [Abstract] [Full Text] [Related]

  • 2. A hepatitis C virus (HCV) internal ribosome entry site (IRES) domain III-IV-targeted aptamer inhibits translation by binding to an apical loop of domain IIId.
    Kikuchi K, Umehara T, Fukuda K, Kuno A, Hasegawa T, Nishikawa S.
    Nucleic Acids Res; 2005; 33(2):683-92. PubMed ID: 15681618
    [Abstract] [Full Text] [Related]

  • 3. Hepatitis C IRES: translating translation into a therapeutic target.
    Jubin R.
    Curr Opin Mol Ther; 2001 Jun; 3(3):278-87. PubMed ID: 11497352
    [Abstract] [Full Text] [Related]

  • 4. Virological effects of ISIS 14803, an antisense oligonucleotide inhibitor of hepatitis C virus (HCV) internal ribosome entry site (IRES), on HCV IRES in chronic hepatitis C patients and examination of the potential role of primary and secondary HCV resistance in the outcome of treatment.
    Soler M, McHutchison JG, Kwoh TJ, Dorr FA, Pawlotsky JM.
    Antivir Ther; 2004 Dec; 9(6):953-68. PubMed ID: 15651754
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Hepatitis C virus internal ribosome entry site (IRES) stem loop IIId contains a phylogenetically conserved GGG triplet essential for translation and IRES folding.
    Jubin R, Vantuno NE, Kieft JS, Murray MG, Doudna JA, Lau JY, Baroudy BM.
    J Virol; 2000 Nov; 74(22):10430-7. PubMed ID: 11044087
    [Abstract] [Full Text] [Related]

  • 12. Sequence-specific cleavage of hepatitis C virus RNA by DNAzymes: inhibition of viral RNA translation and replication.
    Roy S, Gupta N, Subramanian N, Mondal T, Banerjea AC, Das S.
    J Gen Virol; 2008 Jul; 89(Pt 7):1579-1586. PubMed ID: 18559927
    [Abstract] [Full Text] [Related]

  • 13. Development of Optimized Inhibitor RNAs Allowing Multisite-Targeting of the HCV Genome.
    Romero-López C, Lahlali T, Berzal-Herranz B, Berzal-Herranz A.
    Molecules; 2017 May 22; 22(5):. PubMed ID: 28531161
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A peptide derived from RNA recognition motif 2 of human la protein binds to hepatitis C virus internal ribosome entry site, prevents ribosomal assembly, and inhibits internal initiation of translation.
    Pudi R, Ramamurthy SS, Das S.
    J Virol; 2005 Aug 22; 79(15):9842-53. PubMed ID: 16014945
    [Abstract] [Full Text] [Related]

  • 18. [Determination of the in vitro antiviral activity of an engineered M1GS ribozyme that targets to the core gene of hepatitis C virus].
    Zhang W, Li X, Luo G, Huang Z, Liu Y.
    Wei Sheng Wu Xue Bao; 2013 Aug 04; 53(8):875-81. PubMed ID: 24341280
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of Hepatitis C Virus in Mice by a Small Interfering RNA Targeting a Highly Conserved Sequence in Viral IRES Pseudoknot.
    Moon JS, Lee SH, Kim EJ, Cho H, Lee W, Kim GW, Park HJ, Cho SW, Lee C, Oh JW.
    PLoS One; 2016 Aug 04; 11(1):e0146710. PubMed ID: 26751678
    [Abstract] [Full Text] [Related]

  • 20. Interferons specifically suppress the translation from the internal ribosome entry site of hepatitis C virus through a double-stranded RNA-activated protein kinase-independent pathway.
    Kato J, Kato N, Moriyama M, Goto T, Taniguchi H, Shiratori Y, Omata M.
    J Infect Dis; 2002 Jul 15; 186(2):155-63. PubMed ID: 12134250
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.